Catalyst Wire Dossier Catalyst Wire Dossier

TMC647055

· Tibotec Pharmaceuticals, Ireland
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for TMC647055, covering 2013-03-04 to 2016-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007) [Phase 1]

See pricing